pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,888 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: pdufa×type: phase readout×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07560514: Assessment of Digital Technologies for Detection of Dental Caries

    Sponsor: University Hospital, Martin. Phase: NA. Conditions: Dental Caries

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07472816: The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo.

    Sponsor: Cairo University. Phase: PHASE4. Conditions: Vitiligo

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06812416: Effectiveness of Qualia NAD+ Supplementation on NAD Levels

    Sponsor: Qualia Life Sciences. Phase: NA. Conditions: Intracellular NAD+ Levels

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04152616: Mechanisms of Balance Disorders in a Seated Position Following a Stroke

    Sponsor: Rennes University Hospital. Phase: NA. Conditions: Stroke Sequelae

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04848506: Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM

    Sponsor: Cytokinetics. Phase: PHASE2. Conditions: Symptomatic Hypertrophic Cardiomyopathy (HCM)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07651904: Perioperative Respiratory Adverse Events in Cleft Lip and Palate Surgery: Incidence, Risk Factors, and Clinical Scoring

    Sponsor: Marmara University Pendik Training and Research Hospital. Phase: . Conditions: Cleft Palate, Cleft Lip, Laryngospasm, Bronchospasm, Airway Obstruction, Postoperative Complications, Difficult Intubation

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06177704: Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study

    Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval. Phase: . Conditions: Percutaneous Left Atrial Appendage Occlusion (LAAO), Device-related Thrombus (DRT), Thromboembolic Event, Major Cardioembolic Events, Major Bleeding - TIMI Classification

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07553104: Changes in Children and Young People's Well-being and Parental Stress While Seeking Help at CAMHS in Denmark. How Does Waiting Affect CYP and Their Parents Before, During and After CAMHS Assessments.

    Sponsor: Aalborg University Hospital. Phase: . Conditions: Mental Health Help-Seeking, Mental Health Difficulties, Help-Seeking Behavior, Waiting Times, Patient Pathways, Effect of Lifestyle-related, Clinical and Demographic Parameters on Outcomes

    full page →ctgov ↗
    ›WITHDRAWNphase readoutNCT05604404: Effects of Head-of-Bed on Intracranial Pressure

    Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Subarachnoid Hemorrhage, Aneurysmal

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07521384: Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy

    Sponsor: Healing Hope International. Phase: . Conditions: Traumatic Brain Injury, Cerebral Palsy, Hypoxic Ischemic Encephalopathy, Neurologic Disorders, MS (Multiple Sclerosis), Alzheimer Dementia (AD), Parkinson Disease (PD), Stroke, Autism

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06244784: Effectiveness of an Interventional Intervention in Improving the Work Environment of Nurses and Nursing Assistants in the Hospital

    Sponsor: Universitat Internacional de Catalunya. Phase: NA. Conditions: Healthy Work Environment, Burnout, Intention to Leave, Engagement

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07313852: A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE1. Conditions: B-cell Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukemia, Adult, B-ALL

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05528952: Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

    Sponsor: Centre Hospitalier Universitaire de Besancon. Phase: PHASE2. Conditions: Hepatocellular Carcinoma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07657052: A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria

    Sponsor: S-INFINITY Pharmaceuticals Co., Ltd. Phase: NA. Conditions: Paroxysmal Nocturnal Hemoglobinuria

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07452952: Relationship Between the Level of Positive End-expiratory Pressure and Venous Congestion During Acute Respiratory Distress Syndrome.

    Sponsor: University Hospital, Angers. Phase: . Conditions: Mechanical Ventilation, Acute Respiratory Distress Syndrome (ARDS)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06453447: Prednisone for CRPS in Distal Radius Fracture

    Sponsor: University of British Columbia. Phase: NA. Conditions: Complex Regional Pain Syndromes, Distal Radius Fractures

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06818747: Effectiveness of PKP vs DSAEK in Terms of 2-year Postoperative Visual Acuity in Advanced BPK

    Sponsor: Centre Hospitalier Régional Metz-Thionville. Phase: NA. Conditions: Bullous Pseudophakic Keratopathy, Penetrating Keratoplasty

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07559149: Effectiveness of Riboflavin-Moxifloxacin Amniotic Membrane as an Adjuvant for PACK-CXL in Moderate to Severe Infectious Keratitis

    Sponsor: Gadjah Mada University. Phase: PHASE2. Conditions: Infected Corneal Ulcers, CXL

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05966649: Synbiotics in Patients at RIsk fOr Preterm Birth

    Sponsor: Ziekenhuis Oost-Limburg. Phase: NA. Conditions: Preterm Spontaneous Labor With Preterm Delivery, Preterm Birth, Microbial Colonization, Microbiome Dysbiosis, Vaginal Microbiome, Synbiotics

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06824649: Biologics in Chronic Rhinosinusitis With Nasal Polyposis

    Sponsor: Medical University of South Carolina. Phase: PHASE4. Conditions: Chronic Sinusitis, Nasal Polyps

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01767649: Inflammatory Signature of Human Chorionic Cells

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Pregnancy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05720338: Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

    Sponsor: Case Comprehensive Cancer Center. Phase: PHASE3. Conditions: Cyst of Pancreas, Pancreatectomy, Pancreas Neoplasm

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06053138: Assessment of BHB Concentration Agreement Among Sampling Locations and the Impact of Ketosis on EPO, and More

    Sponsor: Central Jutland Regional Hospital. Phase: NA. Conditions: Ketosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04263038: Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

    Sponsor: Drahomir Aujesky. Phase: PHASE4. Conditions: Pulmonary Embolism, Embolism, Embolism and Thrombosis, Lung Diseases, Cardiovascular Diseases, Respiratory Tract Diseases, Venous Thromboembolism, Anticoagulant-induced Bleeding, Bleeding

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07574138: Function of Beta Cells in Early-onset Diabetes Mellitus

    Sponsor: University Medical Center Ho Chi Minh City (UMC). Phase: . Conditions: Type 2 Diabetes Mellitus (T2DM), Beta Cell Function

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05709158: A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal Bow Sai Klib)

    Sponsor: Pfizer. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06031558: Phase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLC

    Sponsor: Shouyao Holdings (Beijing) Co. LTD. Phase: PHASE3. Conditions: Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06864858: Clinical Evaluation of Two Cosmetic Contact Lenses

    Sponsor: Johnson & Johnson Vision Care, Inc.. Phase: NA. Conditions: Visual Acuity

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06822348: Short-term Effects of Osteopathic Manipulations on Heart Rate Variability in Lung Cancer Patients - A Randomized Pilot Study

    Sponsor: Centre Hospitalier Henri Duffaut - Avignon. Phase: NA. Conditions: Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06831955: LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer

    Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: PHASE2. Conditions: Triple Negative Breast Cancer (TNBC), Early Setting

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03737955: Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

    Sponsor: University of Washington. Phase: PHASE2. Conditions: Acute Myeloid Leukemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07480226: Single Versus Multiple Visits Regenerative Endodontics in Mature Teeth

    Sponsor: Marmara University. Phase: NA. Conditions: Chronic Apical Periodontitis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00798226: Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood

    Sponsor: Copenhagen Studies on Asthma in Childhood. Phase: PHASE1. Conditions: Asthma, Eczema, Allergy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03656926: Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

    Sponsor: Zambon SpA. Phase: PHASE3. Conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07625878: Music Effect on Concentration and Gait in Cerebral Palsy Children During Physical Therapy Sessions

    Sponsor: Cairo University. Phase: NA. Conditions: Attention, Gait

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04555278: Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain

    Sponsor: Hugo Massé-Alarie. Phase: NA. Conditions: Chronic Low-back Pain

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02964078: Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer

    Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: PHASE2. Conditions: Kidney Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06793085: Pro- and Anti-inflammatory Cytokines in PCOS

    Sponsor: Jagiellonian University. Phase: . Conditions: Reproductive Age, PCOS (Polycystic Ovary Syndrome)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07476885: A Real World Study of Polyene Phosphatidylcholine Injection for the Prevention and Treatment of DILI in Patients With Malignant Hematological Diseases

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: . Conditions: Drug-Induced Liver Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06661343: Pre-exposure Prophylaxis (PrEP) Adherence for Black MSM

    Sponsor: Yale University. Phase: NA. Conditions: HIV Prevention

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05708443: Effect of Combined Endurance Training on ADL and Walking in COPD Patients

    Sponsor: Istituti Clinici Scientifici Maugeri SpA. Phase: NA. Conditions: COPD

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07618143: The Effects of Somatic-Based Chair Exercises in the Elderly

    Sponsor: Istanbul Gedik University. Phase: NA. Conditions: Elderly (People Aged 65 or More)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07471815: Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy

    Sponsor: Harbin Medical University. Phase: PHASE2. Conditions: Breast Cancer Triple Negative Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07544615: Assessment of IOP After Corneal Refractive Surgery Based on AI

    Sponsor: Tianjin Eye Hospital. Phase: . Conditions: Myopia, Myopia; Astigmatism, Refractive Surgery, Intraocular Pressure Changes

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03240315: Personalized Prediction Strategy for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

    Sponsor: Guangzhou Institute of Respiratory Disease. Phase: . Conditions: Pulmonary Disease, Chronic Obstructive

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07326215: A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+

    Sponsor: Vantive Health LLC. Phase: NA. Conditions: Acute Respiratory Distress Syndrome, Acute Kidney Injury

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02014415: Alpha-1 Antitrypsin Deficiency Adult Liver Study

    Sponsor: St. Louis University. Phase: . Conditions: Alpha-1 Antitrypsin Deficiency

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03157635: Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria

    Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Paroxysmal Hemoglobinuria, Nocturnal

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05062785: Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants

    Sponsor: Robert Silbergleit. Phase: PHASE1. Conditions: Out-Of-Hospital Cardiac Arrest, Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03677908: Plasticity of Neonatal Neuronal Networks Temporal Theta Activity, the First Endogenous

    Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: . Conditions: Premature Birth

    full page →ctgov ↗
    ← prev
    page 70 of 98
    next →